Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is among the best growth stocks to invest in for the next 5 years. The General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), David O.

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is a Massachusetts-based commercial-stage biopharmaceutical company that discovers and commercializes novel therapeutic compounds for underserved diseases.

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Controversy over AB Hernandez's participation in girls' sports included rule changes, federal investigations and online threats to the state of California by President Donald Trump.

APGZX - AB Large Cap Growth Z - Review the APGZX stock price, growth, performance, sustainability and more to help you make the best investments.

But a member of the Alabama Public Library Services board who pushed for the Fairhope Library’s funding freeze in March, says the state money won’t be restored until all books with references ...

13 analysts have expressed a variety of opinions on Apellis Pharmaceuticals APLS over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates ...

Review the current valuation for Apellis Pharmaceuticals Inc (APLS:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

Explore Apellis Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APLS.

It's the latest development in a debate that has been underway for more than a year at the state capitol as lawmakers target criminals who buy children for sex.

State officials want sex education titles moved to adult sections as Alabama faces high STI and teen pregnancy rates, sparking debate over parental rights versus public health concerns.